Irbesartan

Product NDC
63629-5241
11-digit product format
636295241
Labeler code
63629
Product ID
63629-5241_c125c1da-4dbf-404e-9057-131576e823a6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Irbesartan
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA202254
Marketing category
ANDA
Marketing start
2012-09-27
Substance
IRBESARTAN
Active strength
300 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Irbesartan
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
IRBESARTAN300 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiJ0E2756Z7N
Rxcui200096

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
34942a29-de4f-d63c-7755-ba18fe1411a0Product name620180619
a7349398-661d-d9fc-46df-7e128bbd61d9Product name520171113
e0eeb018-194e-4b70-a57d-bac47a97b8eaProduct name120160825

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63629-5241-12019-12-11C16284748780-19855e2a2-4c3e-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997
63629-5241-12019-12-11C16284748780-19855e2a2-4c3e-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997
63629-5241-22019-12-11C16284748780-19855e2a2-4c3e-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997
63629-5241-22019-12-11C16284748780-19855e2a2-4c3e-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997
63629-5241-12019-11-27C16284748780-19855e2a2-4c3e-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997
63629-5241-12019-11-27C16284748780-19855e2a2-4c3e-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997
63629-5241-22019-11-27C16284748780-19855e2a2-4c3e-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997
63629-5241-22019-11-27C16284748780-19855e2a2-4c3e-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-5241-1Irbesartan30 in 1 BOTTLETABLET301009
63629-5241-2Irbesartan90 in 1 BOTTLETABLET901009
63629-5241-3Irbesartan28 in 1 BOTTLETABLET281009
63629-5241-4Irbesartan60 in 1 BOTTLETABLET601009

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
IRBESARTANACTIVE INGREDIENTJ0E2756Z7NIRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
IRBESARTANACTIVE MOIETYJ0E2756Z7NIRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
CARBOXYMETHYLCELLULOSE CALCIUMINACTIVE INGREDIENTUTY7PDF93LIRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)INACTIVE INGREDIENTR75537T0T4IRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XIRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30IRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 3000INACTIVE INGREDIENTSA1B764746IRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
POVIDONE K29/32INACTIVE INGREDIENT390RMW2PEQIRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4IRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2IRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
TALCINACTIVE INGREDIENT7SEV7J4R1UIRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPIRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-5241IRBESARTAN TABLET [BRYANT RANCH PREPACK]1008Current NDC, Legacy NDC, 4 package rows20240524_44b72da1-4434-461f-8e3c-264ad46f85df.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
200096irbesartan 300 MG Oral TabletPSN44b72da1-4434-461f-8e3c-264ad46f85df1009
200096irbesartan 300 MG Oral TabletSCD44b72da1-4434-461f-8e3c-264ad46f85df1009

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63629-5241-16362952410130 TABLET in 1 BOTTLE (63629-5241-1) 30 tablet2014-02-190000-00-00NoNoCurrent
63629-5241-26362952410290 TABLET in 1 BOTTLE (63629-5241-2) 90 tablet2014-02-260000-00-00NoNoCurrent
63629-5241-36362952410328 TABLET in 1 BOTTLE (63629-5241-3) 28 tablet2021-12-220000-00-00NoNoCurrent
63629-5241-46362952410460 TABLET in 1 BOTTLE (63629-5241-4) 60 tablet2021-12-220000-00-00NoNoCurrent